Otriven Sinuspray Für Erwachsene Und Kinder Ab 12 Jahren (Xylometazoline Hydrochloride)

Xylometazoline nasal spray acts on the nasal mucosa to reduce swelling and improve airflow. It is indicated for:

• Common cold: alleviates nasal congestion and improves breathing.
• Acute sinusitis: reduces nasal passage swelling, facilitating sinus drainage.
• Allergic rhinitis: diminishes congestion caused by seasonal or perennial allergens.
• Upper respiratory tract infections: eases blockage of the nasal passages.

• Xylometazoline is a selective alpha‑adrenergic receptor agonist that stimulates alpha‑1 receptors on the smooth muscle of nasal blood vessels. This causes vasoconstriction, leading to reduced mucosal edema and decreased nasal secretions, thereby improving airway patency.

Adverse reactions are generally mild and reversible. Common Side Effects:

• Burning or stinging sensation in the nose.
• Nasal dryness or irritation.
• Sneezing shortly after application.
• Mild headache.
• Transient epistaxis (nosebleeds).
• Unpleasant taste.

Serious or Rare Side Effects

• Persistent nasal irritation or ulceration.
• Severe or prolonged nosebleeds.
• Allergic reactions such as rash, itching or swelling.
• Hypertension exacerbation in susceptible individuals.
• Rebound congestion with prolonged use beyond recommended duration.

Use of Xylometazoline nasal spray requires attention to several safety considerations:

• Limit duration: Do not exceed 3‑7 days of continuous use to avoid rebound congestion.
• Pre‑existing conditions: Use cautiously in patients with hypertension, coronary artery disease, diabetes, hyperthyroidism, or glaucoma.
• Pregnancy and lactation: Consult a healthcare professional before use; limited data are available.
• Pediatric use: Only for individuals 12 years of age and older as indicated.
• Concomitant nasal medications: Avoid using other topical decongestants simultaneously.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Xylometazoline may interact with systemic or topical agents that affect vascular tone or blood pressure.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): may potentiate hypertensive effects.
• Systemic sympathomimetics (e.g., pseudoephedrine): additive vasoconstriction risk.

Moderate Interactions (Monitor Closely)

• Antihypertensive medications: monitor blood pressure for possible elevation.
• Other intranasal decongestants: increased risk of local irritation and rebound congestion.
• Topical ophthalmic alpha‑agonists: potential additive systemic absorption.